1. Division of Medical Oncology, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
2. Department of Medical Oncology, Vall d’Hebron University Hospital, Barcelona, Spain
3. Department of Medical Oncology, Hospital Universitario Málaga General, Instituto de Investigación Biomédica de Málaga, Málaga, Spain
4. Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
5. Oncology Unit GPP, Athens School of Medicine, Athens, Greece
6. Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, South Korea
7. Ege University Faculty of Medicine, Izmir, Turkey
8. Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece
9. Cancer Center, First Hospital Affiliated to Jilin University, Jilin, China
10. Chest Diseases Clinic, Izmir Chest Diseases Research Hospital, Izmir, Turkey
11. Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain
12. Department of Medicine, Ulsan University Hospital, Ulsan, South Korea
13. Medical Oncology Unit, Thoraco-Pulmonary Department, Istituto Nazionale Tumori-IRCCS-“Fondazione G. Pascale,” Naples, Italy
14. Division of Medical Oncology, Sant’Orsola-Malpighi University Hospital, Bologna, Italy
15. Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan
16. National Koranyi Institute, Budapest, Hungary
17. Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
18. Staburo GmbH, Munich, Germany, on behalf of Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
19. Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
20. Boehringer Ingelheim, Danmark A/S, Denmark
21. Department of Medical Oncology, Gustave Roussy Cancer Campus and University Paris-Sud, Paris, France